C. M. Tobin
Impact in
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antimicrobial Resistance in Staphylococcus 5
- Antifungal resistance and susceptibility 1
-
- Antibiotics Pharmacokinetics and Efficacy 5
- Co-authors
- Andrew Lovering (4 shared papers)Alasdair MacGowan (6 shared papers)M.‐A. Gall (1 shared paper)Alison H. Thomson (1 shared paper)Christine E. Staatz (1 shared paper)Edward A. Sweeney (1 shared paper)A. M. Lovering (1 shared paper)Julie Sunderland (3 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)International Journal of Antimicrobial Agents (3 papers)Journal of Infection (1 paper)HAL (Le Centre pour la Communication Scientifique Directe) (1 paper)UCL Discovery (University College London) (1 paper)
- Partner nations
- United KingdomFrance
In The Last Decade
C. M. Tobin
11 papers receiving 409 citations
Peers
Comparison fields: 5 of 63
- Infectious Diseases 229
- Pharmacology 207
- Clinical Biochemistry 76
- Applied Microbiology and Biotechnology 17
- Molecular Medicine 31
Countries citing papers authored by C. M. Tobin
This map shows the geographic impact of C. M. Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. M. Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. M. Tobin more than expected).
Fields of papers citing papers by C. M. Tobin
This network shows the impact of papers produced by C. M. Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. M. Tobin. The network helps show where C. M. Tobin may publish in the future.
Co-authors
The 25 scholars most cited alongside C. M. Tobin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 122 | |
| 2 | 2001 | 71 | |
| 3 | 2005 | 67 | |
| 4 | 2002 | 57 | |
| 5 | 2010 | 45 | |
| 6 | 2006 | 32 | |
| 7 | 2004 | 24 | |
| 8 | 2004 | 4 | |
| 9 | 2002 | 3 | |
| 10 | Maturation of the 5' end of Bacillus subtilis 16S rRNA by the essential ribonuclease YkqC/RNase J1 | 2007 | 2 |
| 11 | The Pharmacokinetic Profiles of Linezolid and Teicoplanin in the critically ill | 2002 | 1 |
About C. M. Tobin
C. M. Tobin is a scholar working on Infectious Diseases, Pharmacology, Food Science, Clinical Biochemistry and Analytical Chemistry, having authored 11 papers that have together received 428 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pesticide Residue Analysis and Safety (3 papers), Analytical Methods in Pharmaceuticals (2 papers), Bacterial Identification and Susceptibility Testing (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Antifungal resistance and susceptibility (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Infectious Diseases (229 citations), Pharmacology (207 citations), Clinical Biochemistry (76 citations), Applied Microbiology and Biotechnology (17 citations) and Molecular Medicine (31 citations). C. M. Tobin has collaborated with scholars based in United Kingdom and France. Frequent co-authors include Andrew Lovering, Alasdair MacGowan, M.‐A. Gall, Alison H. Thomson, Christine E. Staatz, Edward A. Sweeney, A. M. Lovering, Julie Sunderland, Rob Shulman and Leon Aarons. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, Journal of Infection, HAL (Le Centre pour la Communication Scientifique Directe) and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.